NPR News7h agoHealthUnited States
New Treatments and Prevention Methods Tested in DRC and Uganda Ebola Outbreak
Quick Look
- Over 50 days into the Ebola outbreak in DRC and Uganda, clinical trials are underway for new treatments against the rarer Bundibugyo virus.
- Two drugs, remdesivir and MBP-134, are being tested for treatment, while obeldesivir is being studied for post-exposure prevention.
- The trials face challenges including ongoing conflict and community mistrust.
AI-generated summary
Font size
Over 50 days into the Ebola outbreak in DRC and Uganda, clinical trials are underway for new treatments against the rarer Bundibugyo virus. Two drugs, remdesivir and MBP-134, are being tested for treatment, while obeldesivir is being studied for post-exposure prevention. The trials face challenges including ongoing conflict and community mistrust.
Related Topics
This article was originally published by NPR News.
